Roato, I.; Pavone, L.; Pedraza, R.; Bosso, I.; Baima, G.; Erovigni, F.; Mussano, F.
Denosumab and Zoledronic Acid Differently Affect Circulating Immune Subsets: A Possible Role in the Onset of MRONJ. Cells 2023, 12, 2430.
https://doi.org/10.3390/cells12202430
AMA Style
Roato I, Pavone L, Pedraza R, Bosso I, Baima G, Erovigni F, Mussano F.
Denosumab and Zoledronic Acid Differently Affect Circulating Immune Subsets: A Possible Role in the Onset of MRONJ. Cells. 2023; 12(20):2430.
https://doi.org/10.3390/cells12202430
Chicago/Turabian Style
Roato, Ilaria, Lorenzo Pavone, Riccardo Pedraza, Ilaria Bosso, Giacomo Baima, Francesco Erovigni, and Federico Mussano.
2023. "Denosumab and Zoledronic Acid Differently Affect Circulating Immune Subsets: A Possible Role in the Onset of MRONJ" Cells 12, no. 20: 2430.
https://doi.org/10.3390/cells12202430
APA Style
Roato, I., Pavone, L., Pedraza, R., Bosso, I., Baima, G., Erovigni, F., & Mussano, F.
(2023). Denosumab and Zoledronic Acid Differently Affect Circulating Immune Subsets: A Possible Role in the Onset of MRONJ. Cells, 12(20), 2430.
https://doi.org/10.3390/cells12202430